BioNTech SE Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	20,941	25,088	36,506	62,998	18,487	7,666	-	-
Market Cap Growth	-	-31.28%	-42.05%	240.77%	141.16%	-	-	-
Enterprise Value	3,675	7,136	22,322	62,214	17,265	7,176	-402	-142
PE Ratio	21.69	24.27	3.64	5.39	997.33	-38.09	-	-
PS Ratio	4.94	5.91	1.98	2.92	31.43	62.82	-	-
PB Ratio	0.97	1.12	1.71	4.66	11.05	13.83	-	-
P/FCF Ratio	4.20	4.84	2.60	75.01	-155.16	-25.31	-	-
P/OCF Ratio	3.65	4.20	2.53	62.31	-1122.92	-34.37	-	-
EV/Sales Ratio	0.87	1.68	1.21	2.89	29.35	58.81	-2.74	-1.92
EV/EBITDA Ratio	2.47	4.61	1.60	3.55	-336.29	-44.53	14.76	2.44
EV/EBIT Ratio	2.84	5.31	1.62	3.57	-175.22	-36.02	7.65	2.01
EV/FCF Ratio	0.74	1.38	1.59	74.07	-144.91	-23.69	2.79	1.65
Debt / Equity Ratio	0.03	0.03	0.05	0.13	0.25	0.17	0.23	-1.10
Debt / EBITDA Ratio	0.48	0.48	0.08	0.10	-8.21	-0.59	-2.64	-1.12
Debt / FCF Ratio	0.14	0.14	0.08	2.03	-3.54	-0.31	-0.50	-0.75
Quick Ratio	9.17	9.17	7.28	4.18	2.50	3.86	3.42	1.12
Current Ratio	9.43	9.43	7.43	4.33	2.75	4.06	3.56	1.20
Asset Turnover	0.17	0.17	0.79	1.75	0.35	0.15	0.25	0.16
Interest Coverage	50.63	50.63	686.40	50.32	-1.24	-88.65	-25.81	-2.21
Return on Equity (ROE)	4.60%	4.60%	53.00%	143.90%	1.80%	-47.20%	-44.30%	910.00%
Return on Assets (ROA)	4.20%	4.20%	43.20%	94.80%	1.10%	-24.70%	-9.30%	-22.40%
Return on Capital (ROIC)	2.59%	2.59%	43.72%	78.07%	-4.80%	-31.40%	-16.39%	-1270.27%
Earnings Yield	4.94%	4.12%	27.49%	18.57%	0.10%	-2.63%	-	-
FCF Yield	23.81%	20.66%	38.51%	1.33%	-0.64%	-3.95%	-	-
Dividend Yield	0.00%	0.00%	1.40%	0.00%	0.00%	0.00%	-	-
Payout Ratio	0.00%	0.00%	5.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	2.18%	2.18%	0.55%	-7.76%	-0.23%	-	-	-
Total Shareholder Return	2.18%	2.18%	1.95%	-7.76%	-0.23%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).